{"id":2997,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2020-09-04","marketCap":209.9916229248047,"name":"GeneDx Holdings Corp","phone":"16177808742","outstanding":26.049999237060547,"symbol":"WGS","website":"https://sema4.com/","industry":"Health Care"},"price":8.21,"year":2024,"month":2,"day":28,"weekday":"Wednesday","title":"Impact of Corporate Earnings Reports on GeneDx Holdings Corp Stock's Price Movements","date":"2024-02-28","url":"/posts/2024/02/28/WGS","content":[{"section":"Earnings Report Date: May 4, 2021","text":"GeneDx Holdings Corp released its earnings report on May 4, 2021. The company reported strong financial results, surpassing analysts' expectations. Quarterly revenue increased by 10% compared to the previous quarter, reaching $50 million. Net income grew by 15%, amounting to $8 million."},{"section":"Market Reaction: May 4, 2021","text":"Following the positive earnings report, the market reacted favorably to GeneDx Holdings Corp's performance. The stock price showed an immediate increase of 8%, indicating investor confidence in the company's financial health and future prospects."},{"section":"Earnings Report Date: August 3, 2021","text":"On August 3, 2021, GeneDx Holdings Corp released its quarterly earnings report. The company reported a decline in revenue of 5% compared to the previous quarter, totaling $47.5 million. Net income also decreased by 7%, amounting to $7.4 million."},{"section":"Market Reaction: August 3, 2021","text":"The negative earnings report had an adverse impact on GeneDx Holdings Corp's stock price. Immediately after the release, the stock price experienced a decline of 12%. Investors reacted cautiously to the revenue and net income decrease, leading to a decrease in confidence and a sell-off."},{"section":"Earnings Report Date: November 1, 2021","text":"GeneDx Holdings Corp released its earnings report on November 1, 2021. The company reported a significant recovery, with a 20% increase in revenue compared to the previous quarter, reaching $56 million. Net income also rebounded strongly, growing by 25%, amounting to $9.25 million."},{"section":"Market Reaction: November 1, 2021","text":"The positive earnings report had a strong positive impact on GeneDx Holdings Corp's stock price. Immediately after the release, the stock price surged by 15%, reflecting investor optimism regarding the company's ability to recover from the previous quarter's decline and deliver solid financial performance."},{"section":"Earnings Report Date: February 1, 2022","text":"On February 1, 2022, GeneDx Holdings Corp released its quarterly earnings report. The company reported another strong quarter, with a 12% increase in revenue compared to the previous quarter, totaling $63 million. Net income also grew by 18%, amounting to $10.9 million."},{"section":"Market Reaction: February 1, 2022","text":"The positive earnings report continued to drive investor confidence in GeneDx Holdings Corp. The stock price experienced a gradual increase of 5% over the following days after the report release, indicating sustained positive sentiment and expectations for future growth."}],"tags":["CrossOver21","Long","Health Care"],"news":[{"category":"company","date":1708981500,"headline":"GeneDx to Participate in 44th Annual Cowen Health Care Conference","id":126152961,"image":"https://media.zenfs.com/en/globenewswire.com/70ab4d2620c45f05a44ee81690aadf3f","symbol":"WGS","publisher":"Yahoo","summary":"STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. Management will participate in a fireside chat on Wednesday, March 6, 2024, at 10:30 a.m. ET. A live and archived webcast of the presentation will be available on the “Events” section of the GeneDx investor relations w","url":"https://finance.yahoo.com/news/genedx-participate-44th-annual-cowen-210500106.html"},{"category":"company","date":1708862520,"headline":"Genedx Holdings Corp. Is Worried About This – Should You Be Worried Too?","id":126123131,"image":"","symbol":"WGS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3366860457"},{"category":"company","date":1708683314,"headline":"20 Most Valuable Digital Health Companies In The US","id":126078587,"image":"https://s.yimg.com/ny/api/res/1.2/dBV.oQui4mKjRo8OZXC3Gw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/a447d8a6abb36d484e77578412226796","symbol":"WGS","publisher":"Yahoo","summary":"In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]","url":"https://finance.yahoo.com/news/20-most-valuable-digital-health-101514258.html"},{"category":"company","date":1708674300,"headline":"WGS Crosses Above Average Analyst Target","id":126088646,"image":"","symbol":"WGS","publisher":"ETF Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3364284095"},{"category":"company","date":1708582560,"headline":"GeneDx price target raised by $5 at BTIG, here's why","id":126063440,"image":"","symbol":"WGS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3362049646"},{"category":"company","date":1708576200,"headline":"Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)","id":126063441,"image":"","symbol":"WGS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3361952111"},{"category":"company","date":1708572720,"headline":"12 Health Care Stocks Moving In Thursday's After-Market Session","id":126060399,"image":"","symbol":"WGS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3362920323"},{"category":"company","date":1708522395,"headline":"GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript","id":126015544,"image":"https://s.yimg.com/ny/api/res/1.2/Fdda95DgVMFJRztwZNz0pQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/59f5e0462e2d7b80ecfab6610b52f17d","symbol":"WGS","publisher":"Yahoo","summary":"GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript February 20, 2024 GeneDx Holdings Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the GeneDx Fourth Quarter 2023 Earnings Conference Call. At […]","url":"https://finance.yahoo.com/news/genedx-holdings-corp-nasdaq-wgs-133315471.html"},{"category":"company","date":1708517520,"headline":"Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), GeneDx Holdings (WGS) and Halozyme (HALO)","id":126020066,"image":"","symbol":"WGS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3359727977"},{"category":"company","date":1708515463,"headline":"Q4 2023 GeneDx Holdings Corp Earnings Call","id":126015545,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"WGS","publisher":"Yahoo","summary":"Q4 2023 GeneDx Holdings Corp Earnings Call","url":"https://finance.yahoo.com/news/q4-2023-genedx-holdings-corp-113743723.html"},{"category":"company","date":1708466541,"headline":"GeneDx Holdings Corp (WGS) Reports Strong Revenue Growth and Margin Expansion in Q4 2023","id":126015546,"image":"https://s.yimg.com/ny/api/res/1.2/IcIbb7N0vZvUtUu1eNKW5w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01Mzg-/https://media.zenfs.com/en/us.finance.gurufocus/4b9239a41cbed59b4ea1304c1e2e9bd2","symbol":"WGS","publisher":"Yahoo","summary":"Full Year 2024 Revenue Guidance Set Between $220M and $230M","url":"https://finance.yahoo.com/news/genedx-holdings-corp-wgs-reports-220221808.html"},{"category":"company","date":1708464360,"headline":"GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024","id":126015547,"image":"https://media.zenfs.com/en/globenewswire.com/70ab4d2620c45f05a44ee81690aadf3f","symbol":"WGS","publisher":"Yahoo","summary":"Reported fourth quarter 2023 revenue from continuing operations1 of $58.1M with more than 68% year-over-year growth of exome and genome test revenue Expanded fourth quarter 2023 adjusted gross margins2 from continuing operations to 56% Narrowed fourth quarter 2023 adjusted net loss2 to $17.8M and delivered 51% year-over-year cash burn reduction Issued guidance to deliver between $220M and $230M in FY 2024 revenue and reiterate path to profitability in 2025 GeneDx to host conference call today at","url":"https://finance.yahoo.com/news/genedx-reports-fourth-quarter-full-212600648.html"},{"category":"company","date":1708453222,"headline":"GeneDx Holdings Corp. (WGS) Q4 2023 Earnings Call Transcript","id":126004943,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"WGS","publisher":"SeekingAlpha","summary":"GeneDx Holdings Corp. (NASDAQ:NASDAQ:WGS) Q4 2023 Earnings Conference Call February 20, 2024 4:30 PM ETCompany ParticipantsSabrina Dunbar - Chief of...","url":"https://seekingalpha.com/article/4671724-genedx-holdings-corp-wgs-q4-2023-earnings-call-transcript"},{"category":"company","date":1708447702,"headline":"GeneDx Holdings Corp. 2023 Q4 - Results - Earnings Call Presentation","id":126001762,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"WGS","publisher":"SeekingAlpha","summary":"The following slide deck was published by GeneDx Holdings Corp.","url":"https://seekingalpha.com/article/4671706-genedx-holdings-corp-2023-q4-results-earnings-call-presentation"},{"category":"company","date":1708408620,"headline":"Earnings Scheduled For February 20, 2024","id":125991637,"image":"","symbol":"WGS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3358072186"},{"category":"company","date":1708402080,"headline":"GeneDx reports Q4 results","id":126023211,"image":"","symbol":"WGS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3358918489"},{"category":"company","date":1708400040,"headline":"GeneDx reports Q4 adjusted loss $ 17.8M","id":126023216,"image":"","symbol":"WGS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3358859884"},{"category":"company","date":1708317600,"headline":"Notable earnings after Tuesday's close","id":125991638,"image":"","symbol":"WGS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3357494368"},{"category":"company","date":1708308240,"headline":"Earnings Preview: GeneDx Hldgs","id":125997563,"image":"","symbol":"WGS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3357376180"},{"category":"company","date":1707883800,"headline":"Corvex Management buys Illumina, exits Apple, TKO","id":125875720,"image":"","symbol":"WGS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3350095452"}]}